Utilizing ELISA to monitor protein-protein interaction

Methods in Molecular Biology

Volumn 1278, Issue , 2015, Pages 341-352

  Weng, Zusen ^a   Zhao, Qinjian ^a  

^a NONE

Author keywords

Antigen antibody interaction; Binding affinity; Binding analysis in solution; Conformational change; Disulfide bond; Inhibition ELISA; Monoclonal antibody; The half maximal inhibitory concentration (IC50)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5F11; RECOMBINANT HEPATITIS B SURFACE ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANTIGEN; PROTEIN BINDING;

ANTIGENICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; CHEMISTRY; IMMUNOLOGY; PROCEDURES;

ANTIGENS; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; RECOMBINANT PROTEINS;

EID: 84927934274     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2425-7_21     Document Type: Article

References (23)

1. Leng SX, McElhaney JE, Walston JD et al (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63: 879-884.
2. Catt K, Tregear G (1967) Solid-phase radioimmunoassay in antibody-coated tubes. Science 158: 1570.
3. Aviñó A, Gómara M, Malakoutikhah M et al (2012) Oligonucleotide-peptide conjugates: solid-phase synthesis under acidic conditions and use in ELISA assays. Molecules 17: 13825-13843.
4. Yalow RS, Berson SA (1996) Immunoassay of endogenous plasma insulin in man. Obes Res 4: 583-600.
5. Smitsaart EN, Fernandez E, Maradei E et al (1994) Validation of an inhibition ELISA using a monoclonal antibody for foot-andmouth disease (FMD) primary diagnosis. Zentralbl Veterinarmed B 41: 313-319.
6. Aleshukina A, Iagovkin É, Bondarenko V (2011) Change of proinflammatory cytokine profile in human intestine in dysbacteriosis caused by the antibiotics therapy. Zh Mikrobiol Epidemiol Immunobiol: 81-85.
7. Meng Y, High K, Antonello J et al (2005) Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates. Anal Biochem 345: 227-236.
8. Dähnrich C, Komorowski L, Probst C et al (2013) Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421: 213-218.
9. Crowther JR (2000) The ELISA guidebook, vol 149. Humana press, Totowa, New Jersey.
10. Cuervo MLC, de Castro Yanes AF (2004) Comparison between in vitro potency tests for Cuban Hepatitis B vaccine: contribution to the standardization process. Biologicals 32: 171-176.
11. Li H, Shen DT, Jessup DA et al (1996) Prevalence of antibody to malignant catarrhal fever virus in wild and domestic ruminants by competitive-inhibition ELISA. J Wildl Dis 32: 437-443.
12. Tai HC, Campanile N, Ezzelarab M et al (2006) Measurement of anti-CD154 monoclonal antibody in primate sera by competitive inhibition ELISA. Xenotransplantation 13: 566-570.
13. Raj GD, Rajanathan TM, Kumar CS et al (2008) Detection of peste des petits ruminants virus antigen using immunofiltration and antigen-competition ELISA methods. Vet Microbiol 129: 246-251.
14. Dessy FJ, Giannini SL, Bougelet CA et al (2008) Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Hum Vaccin 4: 425-434.
15. Giffroy D, Mazy C, Duchene M (2006) Validation of a new ELISA method for in vitro potency assay of hepatitis B-containing vaccines. Pharmeuropa Bio 2006: 7.
16. Chovel Cuervo ML, Sterling AL, Nicot AI et al (2008) Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers. Biologicals 36: 375-382.
17. Friguet B, Chaffotte AF, Djavadi-Ohaniance L et al (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77: 305-319.
18. Zhao Q, Modis Y, High K et al (2012) Disassembly and reassembly of human papillomavirus virus-like particles produces more virionlike antibody reactivity. Virol J 9: 52.
19. Harrison RO, Goodrow MH, Hammock BD (1991) Competitive inhibition ELISA for the s-triazine herbicides: assay optimization and antibody characterization. J Agric Food Chem 39: 122-128.
20. Zhao Q, Wang Y, Abraham D et al (2011) Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat-and redox-treatment. Biochem Biophys Res Commun 408: 447-453.
21. Zhao Q, Towne V, Brown M et al (2011) In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: Multifaceted biochemical and immunochemical characterization. Vaccine 29: 7936-7941.
22. Mulder AM, Carragher B, Towne V et al (2012) Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. PLoS One 7: e33235.
23. High K, Meng Y, Washabaugh MW et al (2005) Determination of picomolar equilibrium dissociation constants in solution by enzyme-linked immunosorbent assay with fluorescence detection. Anal Biochem 347: 159-161.